Lv1
56 积分 2023-10-07 加入
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy
8小时前
待确认
A CAR enhancer increases the activity and persistence of CAR T cells
1个月前
已完结
Biology and regulation of IL-2: from molecular mechanisms to human therapy
1个月前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
1个月前
已完结
A CAR enhancer increases the activity and persistence of CAR T cells
1个月前
已完结
Who wins the combat, CAR or TCR?
1年前
已完结
The emerging roles of γδ T cells in cancer immunotherapy
1年前
已完结
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
1年前
已完结
皖公网安备34019202002308
